CoChat

GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production

Medsger, Thomas A., Ivanco, Dana E., Kardava, Lela, Morel, Penelope A., Lucas, Mary R., Fuschiotti, Patrizia · 2011 · Arthritis & Rheumatism
Cited by 53

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Despite the importance of interleukin-13 (IL-13) in systemic sclerosis (SSc) and other fibrotic diseases, its mechanisms of action are not understood. We have reported that excessive amounts of IL-13 are produced by peripheral blood effector CD8+ T cells from patients with diffuse cutaneous SSc (dcSSc). The aim of the present study was to establish the molecular basis of IL-13 dysregulation in the pathogenesis of SSc. METHODS: Quantitative polymerase chain reaction analysis and intracellular staining were used to study the transcription factors that control naive peripheral blood CD8+ T cell differentiation into type 1 and type 2 cytokine-secreting cells. Intracellular staining revealed that GATA-3 levels in freshly isolated naive CD8+ T cells correlated with specific clinical manifestations. We therefore assessed the effects of GATA-3 inhibition on IL-13 production in CD8+ T cells from the SSc patients. RESULTS: Freshly isolated naive peripheral blood CD8+ T cells expressed high levels of GATA-3 and failed to down-regulate IL-13 production when cultured under type 1-skewing conditions, but maintained adequate levels of interferon-γ production. Cellular GATA-3 levels were significantly higher in patients with dcSSc and early inflammatory disease. Silencing of GATA-3 with small interfering RNA significantly reduced IL-13 production by CD8+ T cells, demonstrating a causal relationship between GATA-3 and IL-13. CONCLUSION: These results provide important new insights into SSc pathogenesis and suggest that increased GATA-3 expression in CD8+ T cells could be a highly relevant biomarker of immune dysfunction in patients with dcSSc. GATA-3 could be a novel therapeutic target for this currently incurable disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.30489

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 45

  1. Gabrielli, 2009, Scleroderma, N Engl J Med, 360, 1989, 10.1056/NEJMra0806188 · DOI · Paper page
  2. Medsger, 2003, Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being, Rheum Dis Clin North Am, 29, 255, 10.1016/S0889-857X(03)00023-1 · DOI · Paper page
  3. LeRoy, 1988, Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis, J Rheumatol, 15, 202
  4. Gu, 2008, The immunobiology of systemic sclerosis, Semin Arthritis Rheum, 38, 132, 10.1016/j.semarthrit.2007.10.010 · DOI · Paper page
  5. Varga, 2007, Systemic sclerosis: a prototypic multisystem fibrotic disorder, J Clin Invest, 117, 557, 10.1172/JCI31139 · DOI · Paper page
  6. Fleischmajer, 1977, Cellular infiltrates in scleroderma skin, Arthritis Rheum, 20, 975, 10.1002/art.1780200410 · DOI · Paper page
  7. Prescott, 1992, Sequential dermal microvascular and perivascular changes in the development of scleroderma, J Pathol, 166, 255, 10.1002/path.1711660307 · DOI · Paper page
  8. Roumm, 1984, Lymphocytes in the skin of patients with progressive systemic sclerosis: quantification, subtyping, and clinical correlations, Arthritis Rheum, 27, 645, 10.1002/art.1780270607 · DOI · Paper page
  9. Atamas, 1999, Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis, Arthritis Rheum, 42, 1168, 10.1002/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L · doi:10.1002/1529-0131(199906)42:6<1168::aid-anr13>3.0.co;2-l
  10. Chizzolini, 2007, Update on pathophysiology of scleroderma with special reference to immunoinflammatory events, Ann Med, 39, 42, 10.1080/07853890601098152 · DOI
  11. Whiteside, 1984, Products of activated mononuclear cells modulate accumulation of collagen by normal dermal and scleroderma fibroblasts in culture, J Lab Clin Med, 104, 355
  12. Fuschiotti, 2009, Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis, Arthritis Rheum, 60, 1119, 10.1002/art.24432 · DOI
  13. Casciola-Rosen, 1999, Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity, J Exp Med, 190, 815, 10.1084/jem.190.6.815 · DOI · Paper page
  14. Kahaleh, 1997, Mechanism of serum-mediated endothelial injury in scleroderma: identification of a granular enzyme in scleroderma skin and sera, Clin Immunol Immunopathol, 83, 32, 10.1006/clin.1996.4322 · DOI
  15. Wills-Karp, 2008, Untangling the complex web of IL-4- and IL-13-mediated signaling pathways, Sci Signal, 1, pe55, 10.1126/scisignal.1.51.pe55 · DOI · Paper page
  16. Andrew, 1998, STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13, J Immunol, 161, 5027, 10.4049/jimmunol.161.9.5027 · DOI · Paper page
  17. Aliprantis, 2007, Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13, Proc Natl Acad Sci U S A, 104, 2827, 10.1073/pnas.0700021104 · DOI · Paper page
  18. Granel, 2006, Evaluation of interleukin 13 polymorphisms in systemic sclerosis, Immunogenetics, 58, 693, 10.1007/s00251-006-0135-0 · DOI
  19. Granel, 2006, IL13RA2 gene polymorphisms are associated with systemic sclerosis, J Rheumatol, 33, 2015
  20. Agarwal, 1998, Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation, Immunity, 9, 765, 10.1016/S1074-7613(00)80642-1 · DOI · Paper page
  21. Kaplan, 1996, Stat6 is required for mediating responses to IL-4 and for development of Th2 cells, Immunity, 4, 313, 10.1016/S1074-7613(00)80439-2 · DOI · Paper page
  22. Ansel, 2006, Regulation of Th2 differentiation and Il4 locus accessibility, Annu Rev Immunol, 24, 607, 10.1146/annurev.immunol.23.021704.115821 · DOI · Paper page
  23. Lavenu-Bombled, 2002, Interleukin-13 gene expression is regulated by GATA-3 in T cells: role of a critical association of a GATA and two GATG motifs, J Biol Chem, 277, 18313, 10.1074/jbc.M110013200 · DOI
  24. Zhou, 2003, The function role of GATA-3 in Th1 and Th2 differentiation, Immunol Res, 28, 25, 10.1385/IR:28:1:25 · DOI
  25. Kishikawa, 2001, The cell type-specific expression of the murine IL-13 gene is regulated by GATA-3, J Immunol, 167, 4414, 10.4049/jimmunol.167.8.4414 · DOI · Paper page
  26. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, Preliminary criteria for the classification of systemic sclerosis (scleroderma), Arthritis Rheum, 23, 581, 10.1002/art.1780230510 · DOI · Paper page
  27. LeRoy, 2001, Criteria for the classification of early systemic sclerosis, J Rheumatol, 28, 1573
  28. Perera, 2007, Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody, Arthritis Rheum, 56, 2740, 10.1002/art.22747 · DOI
  29. Clements, 1995, Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis, J Rheumatol, 22, 1281
  30. Steen, 2005, Autoantibodies in systemic sclerosis, Semin Arthritis Rheum, 35, 35, 10.1016/j.semarthrit.2005.03.005 · DOI · Paper page
  31. Ho, 2002, Transcription: tantalizing times for T cells, Cell, 109, S109, 10.1016/S0092-8674(02)00705-5 · DOI · Paper page
  32. Needleman, 1992, Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor α, and interferon-γ levels in sera from patients with scleroderma, Arthritis Rheum, 35, 67, 10.1002/art.1780350111 · DOI · Paper page
  33. Atamas, 2003, Cytokine regulation of pulmonary fibrosis in scleroderma, Cytokine Growth Factor Rev, 14, 537, 10.1016/S1359-6101(03)00060-1 · DOI
  34. Constant, 1997, Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches, Annu Rev Immunol, 15, 297, 10.1146/annurev.immunol.15.1.297 · DOI · Paper page
  35. O'Garra, 1998, Cytokines induce the development of functionally heterogeneous T helper cell subsets, Immunity, 8, 275, 10.1016/S1074-7613(00)80533-6 · DOI · Paper page
  36. Gourh, 2009, Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines, Arthritis Rheum, 60, 3794, 10.1002/art.24958 · DOI
  37. Yoshimoto, 2009, Basophils contribute to TH2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells, Nat Immunol, 10, 706, 10.1038/ni.1737 · DOI · Paper page
  38. Ouyang, 2000, Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment, Immunity, 12, 27, 10.1016/S1074-7613(00)80156-9 · DOI · Paper page
  39. Finkelman, 2009, Basophils as TH2-inducing APCs: the dog can sing but is it a diva?, Immunol Cell Biol, 87, 568, 10.1038/icb.2009.67 · DOI
  40. Rankin, 2010, IL-33 induces IL-13-dependent cutaneous fibrosis, J Immunol, 184, 1526, 10.4049/jimmunol.0903306 · DOI · Paper page
  41. Miyahara, 2004, Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness, Nat Med, 10, 865, 10.1038/nm1081 · DOI · Paper page
  42. Ray, 1999, Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation, J Clin Invest, 104, 985, 10.1172/JCI8204 · DOI · Paper page
  43. Nakamura, 1999, Gene expression of the GATA-3 transcription factor is increased in atopic asthma, J Allergy Clin Immunol, 103, 215, 10.1016/S0091-6749(99)70493-8 · DOI · Paper page
  44. Lee, 2004, Transgenic mice which overproduce Th2 cytokines develop spontaneous atopic dermatitis and asthma, Int Immunol, 16, 1155, 10.1093/intimm/dxh117 · DOI · Paper page
  45. Cousins, 2008, Therapeutic approaches for control of transcription factors in allergic disease, J Allergy Clin Immunol, 121, 803, 10.1016/j.jaci.2008.02.008 · DOI

Cited by

Metadata

Authors
Medsger, T. A., Ivanco, D. E., Kardava, L., Morel, P. A., Lucas, M. R., & Fuschiotti, P.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2011-06
Volume
63
Issue
6
Pages
1738-1747
ISSN
0004-3591 (ISSN-L)
OpenAlex
W1966312117
Cited by
53
References
5
FWCI
3.80
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1553 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.